Home › Ulcerative Colitis › Massachusetts › Worcester
Ulcerative Colitis clinical trials in Worcester, MA
3 studies for Ulcerative Colitis are looking for participants at sites in and around Worcester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- UMass Memorial Medical Center - Site Number: 8400121, Worcester
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
RecruitingPhase 2/3
- University of Massachusetts Chan Medical School, Worcester
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 3
- UMass Memorial Medical Center-Site Number: 8400121, Worcester
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- Orlando, FL21 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Houston, TX14 studies
- San Diego, CA13 studies
- Chicago, IL13 studies
- Tacoma, WA13 studies
- St. Louis, MO13 studies
- Tyler, TX13 studies
- San Antonio, TX13 studies
- Colorado Springs, CO12 studies
- Boston, MA12 studies
Other studies in Worcester
- Non-Small Cell Lung Cancer14 studies
- Lung Cancer11 studies
- Cancer (all types)7 studies
- Breast Cancer5 studies
- Metastatic Cancer5 studies
- Acute Myeloid Leukemia5 studies
- Schizophrenia5 studies
- Major Depressive Disorder5 studies
- Prostate Cancer5 studies
- Ovarian Cancer5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Bladder Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.